vs
Side-by-side financial comparison of Burke & Herbert Financial Services Corp. (BHRB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
Burke & Herbert Financial Services Corp. is the larger business by last-quarter revenue ($86.5M vs $83.1M, roughly 1.0× PROCEPT BioRobotics Corp). Burke & Herbert Financial Services Corp. runs the higher net margin — 34.9% vs -38.1%, a 73.0% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 4.9%). Over the past eight quarters, Burke & Herbert Financial Services Corp.'s revenue compounded faster (81.1% CAGR vs 24.8%).
Burke & Herbert Financial Services Corp is a U.S.-based regional financial holding company, offering personal and commercial banking, wealth management, residential mortgage lending, and small business financing services. Its core market covers Virginia and adjacent Mid-Atlantic regions, serving retail consumers, SMEs, and high-net-worth clients.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
BHRB vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $86.5M | $83.1M |
| Net Profit | $30.2M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 43.8% | -4.1% |
| Net Margin | 34.9% | -38.1% |
| Revenue YoY | 4.9% | 20.2% |
| Net Profit YoY | 52.8% | -27.9% |
| EPS (diluted) | $1.98 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $86.5M | $76.4M | ||
| Q3 25 | $85.4M | $83.3M | ||
| Q2 25 | $87.1M | $79.2M | ||
| Q1 25 | $83.0M | $69.2M | ||
| Q4 24 | $82.5M | $68.2M | ||
| Q3 24 | $83.8M | $58.4M | ||
| Q2 24 | $69.3M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $30.2M | $-29.8M | ||
| Q3 25 | $30.0M | $-21.4M | ||
| Q2 25 | $29.9M | $-19.6M | ||
| Q1 25 | $27.2M | $-24.7M | ||
| Q4 24 | $19.8M | $-18.9M | ||
| Q3 24 | $27.6M | $-21.0M | ||
| Q2 24 | $-16.9M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 43.8% | -40.6% | ||
| Q3 25 | 43.3% | -27.8% | ||
| Q2 25 | 42.7% | -28.0% | ||
| Q1 25 | 39.6% | -39.7% | ||
| Q4 24 | 24.6% | -28.9% | ||
| Q3 24 | 39.2% | -38.4% | ||
| Q2 24 | -27.5% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 34.9% | -39.1% | ||
| Q3 25 | 35.1% | -25.7% | ||
| Q2 25 | 34.3% | -24.7% | ||
| Q1 25 | 32.8% | -35.8% | ||
| Q4 24 | 24.0% | -27.6% | ||
| Q3 24 | 33.0% | -35.9% | ||
| Q2 24 | -24.4% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $1.98 | $-0.54 | ||
| Q3 25 | $1.97 | $-0.38 | ||
| Q2 25 | $1.97 | $-0.35 | ||
| Q1 25 | $1.80 | $-0.45 | ||
| Q4 24 | $1.72 | $-0.34 | ||
| Q3 24 | $1.82 | $-0.40 | ||
| Q2 24 | $-1.41 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $854.6M | $347.7M |
| Total Assets | $7.9B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $854.6M | $365.9M | ||
| Q3 25 | $822.2M | $380.3M | ||
| Q2 25 | $780.0M | $385.8M | ||
| Q1 25 | $758.0M | $389.2M | ||
| Q4 24 | $730.2M | $402.2M | ||
| Q3 24 | $738.1M | $241.2M | ||
| Q2 24 | $693.1M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $7.9B | $508.1M | ||
| Q3 25 | $7.9B | $511.5M | ||
| Q2 25 | $8.1B | $513.1M | ||
| Q1 25 | $7.8B | $519.4M | ||
| Q4 24 | $7.8B | $534.0M | ||
| Q3 24 | $7.9B | $374.1M | ||
| Q2 24 | $7.8B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $107.9M | — |
| Free Cash FlowOCF − Capex | $96.2M | — |
| FCF MarginFCF / Revenue | 111.2% | — |
| Capex IntensityCapex / Revenue | 13.5% | — |
| Cash ConversionOCF / Net Profit | 3.57× | — |
| TTM Free Cash FlowTrailing 4 quarters | $164.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $107.9M | $-10.3M | ||
| Q3 25 | $39.3M | $-6.6M | ||
| Q2 25 | $41.0K | $-15.0M | ||
| Q1 25 | $37.6M | $-17.0M | ||
| Q4 24 | $85.8M | $-32.4M | ||
| Q3 24 | $47.8M | $-18.8M | ||
| Q2 24 | $-46.0M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $96.2M | $-12.2M | ||
| Q3 25 | $35.4M | $-9.5M | ||
| Q2 25 | $-3.4M | $-17.8M | ||
| Q1 25 | $35.9M | $-18.8M | ||
| Q4 24 | $81.2M | $-33.6M | ||
| Q3 24 | $46.0M | $-19.0M | ||
| Q2 24 | $-47.0M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 111.2% | -15.9% | ||
| Q3 25 | 41.5% | -11.4% | ||
| Q2 25 | -3.9% | -22.5% | ||
| Q1 25 | 43.2% | -27.2% | ||
| Q4 24 | 98.5% | -49.2% | ||
| Q3 24 | 55.0% | -32.6% | ||
| Q2 24 | -67.8% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 13.5% | 2.4% | ||
| Q3 25 | 4.5% | 3.4% | ||
| Q2 25 | 3.9% | 3.5% | ||
| Q1 25 | 2.1% | 2.7% | ||
| Q4 24 | 5.5% | 1.7% | ||
| Q3 24 | 2.1% | 0.4% | ||
| Q2 24 | 1.5% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 3.57× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 1.38× | — | ||
| Q4 24 | 4.33× | — | ||
| Q3 24 | 1.73× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BHRB
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
